Fullerton Health, a prominent healthcare solutions provider in the Asia-Pacific region, has announced that Mitsubishi Corporation has acquired a strategic minority stake in the company. This partnership aims to enhance shareholder alignment and accelerate Fullerton Health’s vision for integrated, digitally enabled care and services across its nine markets, including Singapore, Indonesia, and the Philippines.
The investment is part of a series of minority investments, including one from Far East Drugs, and is expected to drive Fullerton Health’s expansion in existing markets whilst facilitating entry into new ones. The company plans to leverage its extensive network and digital capabilities to deliver regional and local solutions on a fully integrated platform. Ho Kuen Loon, Group CEO and Non-executive Director of Fullerton Health, stated, “With a shared commitment to impact and innovation, we are well-positioned to achieve our aim to positively impact 10 million lives in coming years.”
Fullerton Health, established in 2010, operates nearly 500 clinics and collaborates with over 18,000 providers across the region. The company offers a comprehensive range of services, from managed care and diagnostics to speciality and ancillary services, combining clinical excellence with tailored corporate healthcare programmes and digital innovation.
BofA Securities served as the sole financial adviser for this transaction. The collaboration with Mitsubishi Corporation underscores a mutual belief in the long-term value and industry leadership potential of Fullerton Health, setting the stage for sustainable growth and enhanced market leadership.
“`
